{"id":"W4407976072","doi":"10.3390/jcm14051561","title":"Accelerating Earlier Access to Anti-TNF-α Agents with Biosimilar Medicines in the Management of Inflammatory Bowel Disease","year":2025,"lang":"en","type":"review","venue":"Journal of Clinical Medicine","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"Hexal AG","keywords":"Biosimilar; Medicine; Inflammatory bowel disease; Intensive care medicine; Infliximab; Tumor necrosis factor alpha; Disease; Formulary; Crohn's disease; Immunology; Pharmacology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006554818,0.0004236953,0.003381326,0.0004895234,0.00006148825,0.0000171521,0.001539107,0.0004597789,0.0003254029],"category_scores_gemma":[0.001833323,0.0001790672,0.000568777,0.000742187,0.0006008463,0.00008337852,0.0002853714,0.00158404,0.000005121666],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002869336,"about_ca_system_score_gemma":0.0003491604,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002815727,"about_ca_topic_score_gemma":0.000003045394,"domain_scores_codex":[0.9934635,0.001572669,0.003937302,0.0003693918,0.0003122872,0.0003448776],"domain_scores_gemma":[0.9940804,0.002972476,0.001987911,0.0005508414,0.0002535131,0.0001549157],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004771618,0.0004309408,0.004198429,0.01679258,0.002050575,0.0006776288,0.00007002434,0.000001466175,0.00000146077,0.0001024033,0.03207234,0.943125],"study_design_scores_gemma":[0.002289557,0.0009924223,0.0343381,0.1070172,0.005326256,0.00005395002,0.0001689586,0.000001196352,0.000002468482,0.00006464331,0.849523,0.0002221878],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003784041,0.9873293,0.0001125925,0.007876112,0.001715406,0.0009977677,0.00001771669,0.000006228824,0.00156649],"genre_scores_gemma":[0.0005506903,0.9943875,0.000537722,0.003746162,0.0004626639,0.00001791126,0.00000915501,0.00001978756,0.0002684293],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9429028,"threshold_uncertainty_score":0.7302147,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.168548071039021,"score_gpt":0.4946549485358143,"score_spread":0.3261068774967933,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}